These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 20540987)

  • 1. Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease.
    Shi M; Zabetian CP; Hancock AM; Ginghina C; Hong Z; Yearout D; Chung KA; Quinn JF; Peskind ER; Galasko D; Jankovic J; Leverenz JB; Zhang J
    Neurosci Lett; 2010 Aug; 480(1):78-82. PubMed ID: 20540987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease.
    Hong Z; Shi M; Chung KA; Quinn JF; Peskind ER; Galasko D; Jankovic J; Zabetian CP; Leverenz JB; Baird G; Montine TJ; Hancock AM; Hwang H; Pan C; Bradner J; Kang UJ; Jensen PH; Zhang J
    Brain; 2010 Mar; 133(Pt 3):713-26. PubMed ID: 20157014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. α-Synuclein and DJ-1 as potential biological fluid biomarkers for Parkinson's Disease.
    Waragai M; Sekiyama K; Sekigawa A; Takamatsu Y; Fujita M; Hashimoto M
    Int J Mol Sci; 2010 Oct; 11(11):4257-66. PubMed ID: 21151436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the DJ-1 protein in the serum of Chinese patients with Parkinson's disease.
    An C; Pu X; Xiao W; Zhang H
    Neurosci Lett; 2018 Feb; 665():236-239. PubMed ID: 29241707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DJ-1 isoforms in whole blood as potential biomarkers of Parkinson disease.
    Lin X; Cook TJ; Zabetian CP; Leverenz JB; Peskind ER; Hu SC; Cain KC; Pan C; Edgar JS; Goodlett DR; Racette BA; Checkoway H; Montine TJ; Shi M; Zhang J
    Sci Rep; 2012; 2():954. PubMed ID: 23233873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cheek cell-derived α-synuclein and DJ-1 do not differentiate Parkinson's disease from control.
    Stewart T; Sui YT; Gonzalez-Cuyar LF; Wong DT; Akin DM; Tumas V; Aasly J; Ashmore E; Aro P; Ginghina C; Korff A; Zabetian CP; Leverenz JB; Shi M; Zhang J
    Neurobiol Aging; 2014 Feb; 35(2):418-20. PubMed ID: 24041968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secretion of DJ-1 into the serum of patients with Parkinson's disease.
    Maita C; Tsuji S; Yabe I; Hamada S; Ogata A; Maita H; Iguchi-Ariga SM; Sasaki H; Ariga H
    Neurosci Lett; 2008 Jan; 431(1):86-9. PubMed ID: 18162323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The significance of oxidized DJ-1 protein (oxDJ-1) as a biomarker for Parkinson's disease].
    Ogawa I; Saito Y; Saigoh K; Hosoi Y; Mitsui Y; Noguchi N; Kusunoki S
    Brain Nerve; 2014 Apr; 66(4):471-7. PubMed ID: 24748095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels of DJ-1 as a possible marker for progression of sporadic Parkinson's disease.
    Waragai M; Nakai M; Wei J; Fujita M; Mizuno H; Ho G; Masliah E; Akatsu H; Yokochi F; Hashimoto M
    Neurosci Lett; 2007 Sep; 425(1):18-22. PubMed ID: 17720313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkinson disease: Progress towards a molecular biomarker for Parkinson disease.
    Foulds P; Mann DM; Mitchell JD; Allsop D
    Nat Rev Neurol; 2010 Jul; 6(7):359-61. PubMed ID: 20639912
    [No Abstract]   [Full Text] [Related]  

  • 11. Biochemical premotor biomarkers for Parkinson's disease.
    Mollenhauer B; Zhang J
    Mov Disord; 2012 Apr; 27(5):644-50. PubMed ID: 22508282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salivary α-synuclein and DJ-1: potential biomarkers for Parkinson's disease.
    Devic I; Hwang H; Edgar JS; Izutsu K; Presland R; Pan C; Goodlett DR; Wang Y; Armaly J; Tumas V; Zabetian CP; Leverenz JB; Shi M; Zhang J
    Brain; 2011 Jul; 134(Pt 7):e178. PubMed ID: 21349902
    [No Abstract]   [Full Text] [Related]  

  • 13. The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease.
    Sharma N; Rao SP; Kalivendi SV
    Free Radic Biol Med; 2019 May; 135():28-37. PubMed ID: 30796974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic activation of NLRP3 inflammasome and plasma α-synuclein levels are correlated with motor severity and progression in Parkinson's disease.
    Fan Z; Pan YT; Zhang ZY; Yang H; Yu SY; Zheng Y; Ma JH; Wang XM
    J Neuroinflammation; 2020 Jan; 17(1):11. PubMed ID: 31915018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A First Tetraplex Assay for the Simultaneous Quantification of Total α-Synuclein, Tau, β-Amyloid42 and DJ-1 in Human Cerebrospinal Fluid.
    Kruse N; Schlossmacher MG; Schulz-Schaeffer WJ; Vanmechelen E; Vanderstichele H; El-Agnaf OM; Mollenhauer B
    PLoS One; 2016; 11(4):e0153564. PubMed ID: 27116005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oligomeric α-synuclein and β-amyloid variants as potential biomarkers for Parkinson's and Alzheimer's diseases.
    Williams SM; Schulz P; Sierks MR
    Eur J Neurosci; 2016 Jan; 43(1):3-16. PubMed ID: 26332448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.
    Mollenhauer B; Locascio JJ; Schulz-Schaeffer W; Sixel-Döring F; Trenkwalder C; Schlossmacher MG
    Lancet Neurol; 2011 Mar; 10(3):230-40. PubMed ID: 21317042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased DJ-1 in urine exosome of Korean males with Parkinson's disease.
    Ho DH; Yi S; Seo H; Son I; Seol W
    Biomed Res Int; 2014; 2014():704678. PubMed ID: 25478574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Problems associated with fluid biomarkers for Parkinson's disease.
    Nyhlén J; Constantinescu R; Zetterberg H
    Biomark Med; 2010 Oct; 4(5):671-81. PubMed ID: 20945980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathological properties of the Parkinson's disease-associated protein DJ-1 in alpha-synucleinopathies and tauopathies: relevance for multiple system atrophy and Pick's disease.
    Neumann M; Müller V; Görner K; Kretzschmar HA; Haass C; Kahle PJ
    Acta Neuropathol; 2004 Jun; 107(6):489-96. PubMed ID: 14991385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.